Pfizer

News

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

UK cues up more Pfizer/BioNTech vaccines as price row looms

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have b

News

BioNTech says repeat doses may be better than modified COVID...

BioNTech has suggested that giving booster doses of its current Comirnaty (BNT162b2) COVID-19 vaccine may be a preferable strategy to modifying the Pfizer-partnered shot.

News

Scotland backs Bavencio for bladder cancer after NICE says n...

Patients with bladder cancer in Scotland will be the first in the UK to claim access to maintenance treatment with Merck Serono and Pfizer's Bavencio, ahead of their counterparts in England

News

Pfizer and Flynn in the firing line again over UK epilepsy d...

The UK's Competition and Markets Authority (CMA) has resurrected a complaint against Pfizer and Flynn Pharma, claiming the two companies charged the NHS excessive prices for a widely-used e

News

UK extends COVID vaccination to 16 and 17-year-olds

The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and 17-year-old children, to tackle an increase in spread of the virus in youn

News

Lilly has a bad hair day as Pfizer rival hits the mark in al...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage tria

UK cues up more Pfizer/BioNTech vaccines as price row looms

BioNTech says repeat doses may be better than modified COVID...

Scotland backs Bavencio for bladder cancer after NICE says n...

Pfizer and Flynn in the firing line again over UK epilepsy d...

UK extends COVID vaccination to 16 and 17-year-olds

Lilly has a bad hair day as Pfizer rival hits the mark in al...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks